Lipid profile, familial hypercholesterolemia prevalence, and 2-year cardiovascular outcome assessment in acute coronary syndrome: Real-life data of a retrospective cohort [Akut koroner sendrom olgularında iki yıllık kardiyovasküler sonlanım değerlendirmesi, lipit profili ve ailevi hiperkolesterolemi sıklığı: Bir geriye dönük kohorta ait gerçek yaşam verileri]
| Autor: | Kayıkçıoğlu M., Alan B., Payzın S., Can L.H. |
|---|---|
| Přispěvatelé: | Ege Üniversitesi |
| Jazyk: | turečtina |
| Rok vydání: | 2019 |
| Předmět: |
ComputingMilieux_MANAGEMENTOFCOMPUTINGANDINFORMATIONSYSTEMS
ComputingMethodologies_PATTERNRECOGNITION Secondary prevention ComputerSystemsOrganization_COMPUTER-COMMUNICATIONNETWORKS Familial hypercholesterolemia Low-density lipoprotein cholesterol Acute coronary syndrome InformationSystems_MISCELLANEOUS Mortality |
| Popis: | PubMed: 31483296 2-s2.0-85071761858 Objective: The aim of this retrospective study based on real-life data was to evaluate the lipid profile and demographic, clinical, and laboratory features of patients with acute coronary syndrome (ACS) at a tertiary center and to examine the mortality rate. Methods: Information including endpoint data for at least 2 years following the index ACS event was retrieved from hospital records. Patients without sufficient follow-up data were called by phone. Modified Dutch Lipid Clinic Network criteria were used to identify the presence of familial hypercholesterolemia (FH). Factors affecting mortality in the 2-year followup period were evaluated using Cox regression analysis. Results: A total of 985 ACS patients (215 females) between 21 and 93 years of age were included. The females were older and had a lower smoking rate than the males. In females, the history of obesity and hypertension, the diabetes rate, and the thyroid-stimulating hormone level were higher than those of the males. In 95.6% of the patients, lipid parameters were measured upon hospital admission. No significant difference in dyslipidemia frequency was observed between genders. The frequency of FH was 7.6%. The rate of lipid-lowering drug use was 90% at discharge, and decreased to 50% in the follow-up period. The mortality rate was 3.8% in the in-hospital period and 8.1% during the 2 years of follow-up. Conclusion: The mortality rate in ACS patients was 3.8% in the in-hospital period and 8.1% in the 2-year follow-up period. The frequency of hypercholesterolemia was 89.5% and the rate of lipid-lowering drug use was insufficient. Secondary prevention after ACS was not adequately employed even at a tertiary center. The FH frequency was 7.6% and those with FH were observed to have ACS at a younger age than those without. © 2019 Türk Kardiyoloji Derneği |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|